{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:23:22Z","timestamp":1787952202065,"version":"build-2784847793"},"reference-count":265,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01KT2306B"],"award-info":[{"award-number":["01KT2306B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.blre.2026.101416","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:34:27Z","timestamp":1782948867000},"page":"101416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A tale of two sites \u2013 Distinct spatial differences between bone marrow and extramedullary AML"],"prefix":"10.1016","volume":"77","author":[{"given":"Hossein","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette I.","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Frimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2026.101416_bb0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101416_bb0010","article-title":"Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysis","volume":"59","author":"Baden","year":"2025","journal-title":"Lancet Reg Health Europe"},{"key":"10.1016\/j.blre.2026.101416_bb0015","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/cancers14112806","article-title":"New therapeutic strategies for adult acute myeloid Leukemia","volume":"14","author":"Ishii","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.blre.2026.101416_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811144","article-title":"Tumor microenvironment in acute myeloid Leukemia: adjusting niches","volume":"13","author":"Menter","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb0030","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI96313","article-title":"Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers","volume":"129","author":"Gruosso","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2026.101416_bb0035","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of Cancer-associated fibroblasts promote T-cell exclusion in human lung Tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.blre.2026.101416_bb0040","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3324\/haematol.2018.197004","article-title":"Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis","volume":"103","author":"Le","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031328","article-title":"The bone marrow microenvironment in health and myeloid malignancy","volume":"8","author":"Gal\u00e1n-D\u00edez","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.blre.2026.101416_bb0050","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3324\/haematol.2011.045047","article-title":"18F-FDG-PET\/CT for detection of extramedullary acute myeloid leukemia","volume":"96","author":"St\u00f6lzel","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2026.101416_bb0060","series-title":"Acute Myeloid Leukemia","first-page":"275","article-title":"Special clinical scenarios: Extramedullary disease","author":"St\u00f6lzel","year":"2021"},{"key":"10.1016\/j.blre.2026.101416_bb0065","doi-asserted-by":"crossref","DOI":"10.21037\/acr-20-110","article-title":"Isolated myeloid sarcoma of lumbar spine without bone marrow involvement: a rare case report and treatment dilemma","volume":"5","author":"Bhandohal","year":"2021","journal-title":"AME Case Rep"},{"key":"10.1016\/j.blre.2026.101416_bb0070","doi-asserted-by":"crossref","unstructured":"Aslam HM, Veeraballi S, Saeed Z, Weil A, Chaudhary V. Isolated myeloid sarcoma: a diagnostic dilemma. Cureus 14:e21200. Doi: https:\/\/doi.org\/10.7759\/cureus.21200.","DOI":"10.7759\/cureus.21200"},{"key":"10.1016\/j.blre.2026.101416_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5045\/br.2017.52.3.184","article-title":"Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience","volume":"52","author":"Lee","year":"2017","journal-title":"Blood Res"},{"key":"10.1016\/j.blre.2026.101416_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3324\/haematol.2012.073189","article-title":"Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"98","author":"Harris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0085","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220953","article-title":"Skin mesenchymal niches maintain and protect AML-initiating stem cells","volume":"220","author":"Sandhow","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2026.101416_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.665763","article-title":"Adipocytes provide fatty acids to acute lymphoblastic Leukemia cells","volume":"11","author":"Tucci","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/01926230600867743","article-title":"Normal structure, function, and histology of the spleen","volume":"34","author":"Cesta","year":"2006","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.blre.2026.101416_bb0100","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/leu.2015.81","article-title":"Next generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma","volume":"29","author":"Li","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2017-09-804906","article-title":"Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration","volume":"131","author":"Caraffini","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10428194.2017.1339879","article-title":"Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing","volume":"59","author":"Kashofer","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2026.101416_bb0115","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.3324\/haematol.2018.197277","article-title":"Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900","volume":"104","author":"Fernandez","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb0125","series-title":"Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing","author":"Collignon","year":"2025"},{"key":"10.1016\/j.blre.2026.101416_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11912-020-0885-0","article-title":"Acute myeloid leukaemia in its niche: the bone marrow microenvironment in acute myeloid leukaemia","volume":"22","author":"Ladikou","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.blre.2026.101416_bb0135","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/s41375-020-0886-x","article-title":"Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders?","volume":"34","author":"Zinngrebe","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.692800","article-title":"Macrophages in acute myeloid leukaemia: significant players in therapy resistance and patient outcomes","volume":"9","author":"Miari","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.blre.2026.101416_bb0145","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41375-024-02337-0","article-title":"Clinical and molecular characteristics of extramedullary acute myeloid leukemias","volume":"38","author":"Kewan","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0150","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1242\/jcs.00633","article-title":"Fluorescence in situ hybridization: past, present and future","volume":"116","author":"Levsky","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.blre.2026.101416_bb0155","series-title":"Gene expression analysis: Methods and protocols","first-page":"101","article-title":"Spatial-omics methods and applications","author":"Kulasinghe","year":"2025"},{"key":"10.1016\/j.blre.2026.101416_bb0160","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41587-022-01536-3","article-title":"Integrated protein and transcriptome spatial profiling","volume":"41","author":"Ben-Chetrit","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.blre.2026.101416_bb0165","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41598-022-05841-4","article-title":"MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors","volume":"12","author":"Kinkhabwala","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101416_bb0170","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2016-10-696039","article-title":"Therapeutic targeting of acute myeloid leukemia stem cells","volume":"129","author":"Pollyea","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.20892\/j.issn.2095-3941.2016.0023","article-title":"Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: yin and Yang","volume":"13","author":"Zhou","year":"2016","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.blre.2026.101416_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.764698","article-title":"The bone marrow microenvironment mechanisms in acute myeloid Leukemia","volume":"9","author":"Pimenta","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.blre.2026.101416_bb0185","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.37349\/etat.2024.00262","article-title":"Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche","volume":"5","author":"Khattab","year":"2024","journal-title":"Explor Targeted Anti-tumor Ther"},{"key":"10.1016\/j.blre.2026.101416_bb0190","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/0008-5472.CAN-10-3220","article-title":"Cancer stem cell niche: the place to be","volume":"71","author":"Borovski","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2026.101416_bb0195","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature12883","article-title":"Leukaemogenesis induced by an activating \u03b2-catenin mutation in osteoblasts","volume":"506","author":"Kode","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0200","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nature20131","article-title":"Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment","volume":"539","author":"Dong","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0205","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2026.101416_bb0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.blre.2026.101416_bb0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41580-019-0103-9","article-title":"Haematopoietic stem cell activity and interactions with the niche","volume":"20","author":"Pinho","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.blre.2026.101416_bb0220","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","article-title":"Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging","volume":"187","author":"Bandyopadhyay","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.blre.2026.101416_bb0225","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood.V126.23.2403.2403","article-title":"Acute myeloid leukemia (AML) cells alter the bone marrow microenvironment by inducing osteogenic and suppressing adipogenic differentiation of MSCs through BMP-RUNX2-CTGF mediated mechanisms","volume":"126","author":"Battula","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117413","article-title":"Detailed characterization of bone marrow adipose tissue mesenchymal stem cells in healthy donor, Fanconi anemia, and acute myeloid leukemia","volume":"193","author":"Murato\u011flu","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.blre.2026.101416_bb0235","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2008-10-184754","article-title":"Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization","volume":"114","author":"Christopher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0240","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11899-015-0253-6","article-title":"Role of microenvironment in resistance to therapy in AML","volume":"10","author":"Tabe","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.blre.2026.101416_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0250","first-page":"557","article-title":"Osteoclast activation by receptor activator of NF-\u03baB ligand enhances the mobilization of hematopoietic progenitor cells from the bone marrow in acute injury","volume":"26","author":"Cho","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.blre.2026.101416_bb0255","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MOH.0b013e3283475fe7","article-title":"Hierarchy of immature hematopoietic cells related to blood flow and niche","volume":"18","author":"L\u00e9vesque","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/leu.2008.381","article-title":"Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon?","volume":"23","author":"Ribatti","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V95.1.309","article-title":"Evidence of increased angiogenesis in patients with acute myeloid leukemia","volume":"95","author":"Hussong","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0270","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/leu.2014.109","article-title":"Functional integration of acute myeloid leukemia into the vascular niche","volume":"28","author":"Cogle","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5043483","article-title":"Role of microvessel density and vascular endothelial growth factor in angiogenesis of hematological malignancies","volume":"2016","author":"Chand","year":"2016","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.blre.2026.101416_bb0280","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00018-012-1085-3","article-title":"Vascular endothelial growth factor signaling in acute myeloid leukemia","volume":"70","author":"Kampen","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.blre.2026.101416_bb0285","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","article-title":"Acute myelogenous Leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche","volume":"15","author":"Hanoun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.blre.2026.101416_bb0290","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","article-title":"Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid Leukemia","volume":"32","author":"Passaro","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.blre.2026.101416_bb0295","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000151","article-title":"Mesenchymal stromal cells: role in the BM niche and in the support of hematopoietic stem cell transplantation","volume":"2","author":"Crippa","year":"2018","journal-title":"Hemasphere"},{"key":"10.1016\/j.blre.2026.101416_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1325291","article-title":"Mesenchymal stromal cells, metabolism, and mitochondrial transfer in bone marrow normal and malignant hematopoiesis","volume":"11","author":"Singh","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.blre.2026.101416_bb0305","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41375-018-0373-9","article-title":"Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges","volume":"33","author":"Lee","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0310","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3324\/haematol.2009.015065","article-title":"CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties","volume":"95","author":"Ku\u00e7i","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0315","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/bloodadvances.2017013870","article-title":"Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice","volume":"2","author":"Xiao","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101416_bb0320","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.leukres.2017.10.006","article-title":"DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia","volume":"63","author":"Ozdogan","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2026.101416_bb0325","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0330","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.stem.2018.07.006","article-title":"Gli1+ mesenchymal stromal cells are a key driver of bone marrow fibrosis and an important cellular therapeutic target","volume":"23","author":"Schneider","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.blre.2026.101416_bb0335","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13287-017-0649-4","article-title":"Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells","volume":"8","author":"Madsen","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.blre.2026.101416_bb0340","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.7150\/ijbs.61950","article-title":"Single-cell RNA sequencing deconvolutes the in vivo heterogeneity of human bone marrow-derived mesenchymal stem cells","volume":"17","author":"Wang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.blre.2026.101416_bb0345","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.20101688","article-title":"Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche","volume":"208","author":"Chow","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2026.101416_bb0350","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000500315","article-title":"The role of tumor-associated macrophages in Leukemia","volume":"143","author":"Li","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2026.101416_bb0355","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004794","article-title":"TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis","volume":"10","author":"Brauneck","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb0360","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.3390\/cancers13215289","article-title":"CSF1R inhibition combined with GM-CSF reprograms macrophages and disrupts Protumoral interplays with AML cells","volume":"13","author":"Smirnova","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.blre.2026.101416_bb0365","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.it.2023.10.009","article-title":"Reframing macrophage diversity with network motifs","volume":"44","author":"Pizzurro","year":"2023","journal-title":"Trends Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb0370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0375","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1126\/science.2163544","article-title":"Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta","volume":"248","author":"Sieweke","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.blre.2026.101416_bb0380","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0385","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000141","article-title":"Leukemia cutis in childhood acute myeloid Leukemia: epidemiological, clinical, biological, and prognostic characteristics of patients included in the ELAM02 study","volume":"2","author":"Gouache","year":"2018","journal-title":"HemaSphere"},{"key":"10.1016\/j.blre.2026.101416_bb0390","series-title":"Cellular populations isolated from newborn mouse skin including mesenchymal stem cells","author":"Kimlin","year":"2026"},{"key":"10.1016\/j.blre.2026.101416_bb0395","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/pbc.22500","article-title":"Chemokine\/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles for CCR2, CCR5, CXCR4 and CXCR7","volume":"55","author":"Faaij","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb0400","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-2483","article-title":"Mechanisms of immune escape and extramedullary tropism in leukemia cutis","author":"Penter","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0405","doi-asserted-by":"crossref","first-page":"68","DOI":"10.21037\/atm-20-3140","article-title":"A narrative review of central nervous system involvement in acute leukemias","volume":"9","author":"Deak","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.blre.2026.101416_bb0410","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13287-016-0373-5","article-title":"Expression of neural cell adhesion molecule and polysialic acid in human bone marrow-derived mesenchymal stromal cells","volume":"7","author":"Skog","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.blre.2026.101416_bb0415","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-014-0071-7","article-title":"Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen","volume":"7","author":"Ma","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1000996","article-title":"The cytokine network in acute myeloid leukemia","volume":"13","author":"Luciano","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb0425","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.clml.2018.03.013","article-title":"Myeloid sarcoma predicts superior outcome in Pediatric AML; can cytogenetics solve the puzzle?","volume":"18","author":"Pramanik","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.blre.2026.101416_bb0430","article-title":"Bilateral orbital myeloid sarcomas: a unique presentation of acute myeloid Leukemia","volume":"14","author":"Stephenson","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.blre.2026.101416_bb0435","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jcor.jcor_135_23","article-title":"A rare case of orbital involvement in myeloid sarcoma \u2013 report of two pediatric cases from North India with review of literature","volume":"14","author":"Wadhwani","year":"2026","journal-title":"J Clin Ophthalmol Res"},{"key":"10.1016\/j.blre.2026.101416_bb0440","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1148\/rg.284085013","article-title":"From the archives of the AFIP. Pediatric orbit tumors and tumorlike lesions: osseous lesions of the orbit","volume":"28","author":"Chung","year":"2008","journal-title":"Radiographics"},{"key":"10.1016\/j.blre.2026.101416_bb0445","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s13256-021-03025-8","article-title":"Orbital myeloid sarcoma misdiagnosed for subperiostal hematoma: a case report","volume":"15","author":"Razem","year":"2021","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.blre.2026.101416_bb0450","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.1993.11.4.690","article-title":"Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia","volume":"11","author":"Tallman","year":"1993","journal-title":"JCO"},{"issue":"Supplement 1","key":"10.1016\/j.blre.2026.101416_bb0455","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1182\/blood-2025-5255","article-title":"Allograft inflammatory factor \u22121 is essential for acute monocytic leukemia infiltration","volume":"146","author":"Chen","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0460","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3065464","article-title":"Ginsenoside Rk3 inhibits the extramedullary infiltration of acute monocytic leukemia cell via miR-3677-5p\/CXCL12 axis","volume":"2022","author":"Ma","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"Supplement 1","key":"10.1016\/j.blre.2026.101416_bb0465","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1182\/blood-2025-5288","article-title":"CD15 expression on leukemic cells associates with extramedullary infiltration and adverse outcomes in acute myeloid Leukemia","volume":"146","author":"Li","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0470","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood.V114.22.3119.3119","article-title":"The essential roles of TIMP-2, MT1-MMP, and MMP-2 in the invasive capacity of SHI-1 leukemic cells","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0475","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1182\/blood.V124.21.5298.5298","article-title":"MLAA-34: a new Leukemia-associated antigen for immunotherapy against acute monocytic Leukemia","volume":"124","author":"Bai","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-025-01345-2","article-title":"Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing","volume":"15","author":"Collignon","year":"2025","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2026.101416_bb0485","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1200\/JCO.2004.08.060","article-title":"Acute monocytic Leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid Leukemia: a report from the eastern cooperative oncology group","volume":"22","author":"Tallman","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb0490","first-page":"44","article-title":"Molecular and cellular aspects of extramedullary manifestations of acute myeloid leukemia","volume":"2","author":"Mohammadiasl","year":"2016","journal-title":"jcmt"},{"key":"10.1016\/j.blre.2026.101416_bb0495","series-title":"\u03b14\u03b21 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B\/MMP-9 in chronic leukemic but not in normal B cells","author":"Redondo-Mu\u00f1oz","year":"2008"},{"key":"10.1016\/j.blre.2026.101416_bb0500","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2026.101416_bb0505","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fonc.2018.00444","article-title":"Acute myeloid Leukemia and the bone marrow niche\u2014take a closer look","volume":"8","author":"Behrmann","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb0510","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3324\/haematol.2019.231944","article-title":"CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity","volume":"106","author":"Gutjahr","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0515","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood-2007-12-124818","article-title":"Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia","volume":"113","author":"Becker","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0520","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.canlet.2015.05.007","article-title":"Acute myeloid leukemia in the vascular niche","volume":"380","author":"Cogle","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.blre.2026.101416_bb0525","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/s41375-023-02054-0","article-title":"Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial\u2013mesenchymal transition pathways","volume":"37","author":"Ottone","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084430","article-title":"Transforming the niche: the emerging role of extracellular vesicles in acute myeloid leukaemia progression","volume":"25","author":"Mendes","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2026.101416_bb0535","article-title":"The extracellular matrix of human bone marrow adipocytes and glucose concentration differentially alter mineralization quality without impairing osteoblastogenesis","volume":"17","author":"Entz","year":"2022","journal-title":"Bone Rep"},{"key":"10.1016\/j.blre.2026.101416_bb0540","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2020.07.010","article-title":"\u201cCaught in the net\u201d: the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia","volume":"89","author":"Zanetti","year":"2020","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb0545","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201157","article-title":"Discriminant principal component analysis of ToF-SIMS spectra for deciphering compositional differences of MSC-secreted extracellular matrices","volume":"7","author":"Zimmermann","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.blre.2026.101416_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2024.1334807","article-title":"Exploring the intricate cross-talk between clonal expansion and the bone marrow niche","volume":"3","author":"Ngo","year":"2024","journal-title":"Front Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb0555","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/leu.2008.48","article-title":"The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites","volume":"22","author":"Shiozawa","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb0560","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0565","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/17474086.2014.958464","article-title":"The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment","volume":"7","author":"Isidori","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb0570","series-title":"Tumor cell heterogeneity drives spatial organization of the intratumoral immune response in squamous cell skin carcinoma","author":"Tanaka","year":"2023"},{"key":"10.1016\/j.blre.2026.101416_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz0463","article-title":"Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia","volume":"12","author":"Vadakekolathu","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.blre.2026.101416_bb0580","series-title":"Multimodal spatial proteomic profiling in acute myeloid leukemia","author":"Ly","year":"2024"},{"key":"10.1016\/j.blre.2026.101416_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/ebm.2025.10235","article-title":"Bone marrow immune cells and drug resistance in acute myeloid leukemia","volume":"250","author":"Zhang","year":"2025","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.blre.2026.101416_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100991","article-title":"Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment","volume":"57","author":"Serroukh","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2026.101416_bb0595","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/imm.12665","article-title":"Functional exhaustion of CD4+ T cells induced by co-stimulatory signals from myeloid leukaemia cells","volume":"149","author":"Ozkazanc","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.blre.2026.101416_bb0600","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2026.101416_bb0605","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2010-03-275446","article-title":"Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0610","first-page":"27","article-title":"An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia","volume":"4","author":"Lasry","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb0615","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in Tumors: from mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb0620","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000168","article-title":"Myeloid-derived suppressor cells in hematologic diseases: promising biomarkers and treatment targets","volume":"3","author":"Bizymi","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.blre.2026.101416_bb0625","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.blre.2026.101416_bb0630","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2016-07-730614","article-title":"MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia","volume":"129","author":"Pyzer","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0635","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1158\/0008-5472.CAN-15-1320","article-title":"Multiple myeloma impairs bone marrow localization of effector natural killer cells by altering the chemokine microenvironment","volume":"75","author":"Ponzetta","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2026.101416_bb0640","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3324\/haematol.2013.087536","article-title":"Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia","volume":"99","author":"Stringaris","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0645","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1683347","article-title":"The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia","volume":"9","author":"Xu","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.blre.2026.101416_bb0650","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.2016.143180","article-title":"Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a growth factor independence 1 dependent manner","volume":"101","author":"Al-Matary","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0655","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf8522","article-title":"M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism","volume":"9","author":"Weinh\u00e4user","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.blre.2026.101416_bb0660","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb0665","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0670","article-title":"Generation of myeloid cells in cancer: the spleen matters","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb0675","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0145-2126(89)90042-8","article-title":"Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): association of T-cell-related antigens and skin-infiltration in AMOL","volume":"13","author":"Schwonzen","year":"1989","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2026.101416_bb0680","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1182\/blood-2011-07-365817","article-title":"Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?","volume":"118","author":"Ustun","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0685","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exphem.2016.10.005","article-title":"Tumor necrosis factor \u03b1 in the onset and progression of leukemia","volume":"45","author":"Zhou","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb0690","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/sj.onc.1207317","article-title":"Expression of both TNF-\u03b1 receptor subtypes is essential for optimal skin tumour development","volume":"23","author":"Arnott","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2026.101416_bb0695","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.192.12.1809","article-title":"Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice","volume":"192","author":"Knight","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2026.101416_bb0700","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood-2015-01-624833","article-title":"Transmembrane TNF-\u03b1 preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy","volume":"126","author":"Zhou","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0705","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/716c0fb2-dbdd-4da5-ad8a-d2b1cdac4ec6","article-title":"Matrix Metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins","volume":"6","author":"Feng","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.blre.2026.101416_bb0710","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/cncr.31896","article-title":"The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia","volume":"125","author":"Williams","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb0715","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/10428194.2019.1675880","article-title":"PD-1\/PD-L1 expression in extramedullary lesions of acute myeloid leukemia","volume":"62","author":"Meleveedu","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2026.101416_bb0720","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax5851","article-title":"MIBI-TOF: a multiplexed imaging platform relates cellular phenotypes and tissue structure","volume":"5","author":"Keren","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.blre.2026.101416_bb0725","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/BST20150254","article-title":"Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells","volume":"44","author":"Ager","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.blre.2026.101416_bb0730","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb0735","doi-asserted-by":"crossref","unstructured":"Huang S, Zhao Y, Lai W, Tan J, Zheng X, Zha X, et al. Higher PD-1\/Tim-3 expression on IFN-\u03b3+ T cells is associated with poor prognosis in patients with acute myeloid leukemia. Cancer Biol Ther 24:2278229. Doi: https:\/\/doi.org\/10.1080\/15384047.2023.2278229.","DOI":"10.1080\/15384047.2023.2278229"},{"key":"10.1016\/j.blre.2026.101416_bb0740","series-title":"Spatial transcriptomics reveals inflammation and trans-differentiation states of acute myeloid leukemia in extramedullary and medullary tissues","author":"Dasdemir","year":"2024"},{"issue":"Supplement 1","key":"10.1016\/j.blre.2026.101416_bb0745","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood-2024-203816","article-title":"Multimodal spatial profiling in acute myeloid Leukemia","volume":"144","author":"Ly","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0750","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.2024024590","article-title":"Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma","volume":"144","author":"John","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0755","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41586-021-04217-4","article-title":"Spatial genomics enables multi-modal study of clonal heterogeneity in tissues","volume":"601","author":"Zhao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0760","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41586-020-03126-2","article-title":"Integrated spatial genomics reveals global architecture of single nuclei","volume":"590","author":"Takei","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0765","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-05425-2","article-title":"Spatial genomics maps the structure, nature and evolution of cancer clones","volume":"611","author":"Lomakin","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101416_bb0770","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4161\/cc.5.6.2577","article-title":"From mice to human: the \u201ctwo-hit model\u201d of leukemogenesis","volume":"5","author":"Kosmider","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.blre.2026.101416_bb0775","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411259","article-title":"Genetic abnormalities in extramedullary multiple myeloma","volume":"24","author":"McAvera","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2026.101416_bb0785","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.V99.6.1909","article-title":"Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia","volume":"99","author":"Pedersen-Bjergaard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0790","first-page":"328","article-title":"Acute myeloid Leukemia\u2014genetic alterations and their clinical prognosis","volume":"11","author":"Lagunas-Rangel","year":"2017","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.blre.2026.101416_bb0795","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","article-title":"Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia","volume":"128","author":"Metzeler","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0800","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12935-024-03368-4","article-title":"Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes","volume":"24","author":"Kim","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.blre.2026.101416_bb0805","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2008-03-145862","article-title":"Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes","volume":"113","author":"Kuwatsuka","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0810","series-title":"Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas","author":"Falini","year":"2007"},{"key":"10.1016\/j.blre.2026.101416_bb0815","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"Ali Ansari-Lari","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101416_bb0820","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1182\/blood.V120.21.2592.2592","article-title":"Cytogenetic and molecular characterization of extramedullary disease (EMD) in patients (pts) with acute myeloid Leukemia (AML)","volume":"120","author":"Pemmaraju","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0825","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.humpath.2020.11.005","article-title":"Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia","volume":"108","author":"Greenland","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.blre.2026.101416_bb0830","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ejh.13056","article-title":"Clinicopathological characteristics of de novo and secondary myeloid sarcoma: a monocentric retrospective study","volume":"100","author":"Claerhout","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2026.101416_bb0835","first-page":"333","article-title":"Myeloid sarcoma with CBFB-MYH11 fusion (inv(16) or t(16;16)) prevails in the abdomen: a clinicopathologic analysis of 11 cases and review of the literature","volume":"153","author":"Dalland","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2026.101416_bb0840","series-title":"RAS-mutant clones drive extramedullary acute myeloid leukemia","author":"Chaida","year":"2026"},{"key":"10.1016\/j.blre.2026.101416_bb0845","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1325431","article-title":"Genetic alterations in myeloid sarcoma among acute myeloid leukemia patients: insights from 37 cohort studies and a meta-analysis","volume":"14","author":"Untaaveesup","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb0850","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7150\/ijbs.13382","article-title":"Nucleophosmin mutants promote adhesion, migration and invasion of human Leukemia THP-1 cells through MMPs up-regulation via Ras\/ERK MAPK Signaling","volume":"12","author":"Xian","year":"2016","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.blre.2026.101416_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17243975","article-title":"Clinical and molecular characterization of myeloid sarcoma: a systematic review and meta-analysis","volume":"17","author":"Padmanabhan","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.blre.2026.101416_bb0860","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5045\/br.2023.2023024","article-title":"Recent advances in diagnosis and therapy in systemic mastocytosis","volume":"58","author":"Lee","year":"2023","journal-title":"Blood Res"},{"key":"10.1016\/j.blre.2026.101416_bb0865","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bjh.17405","article-title":"Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series","volume":"193","author":"Tanasi","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101416_bb0870","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.thj.6200336","article-title":"Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature","volume":"5","author":"Sugimoto","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.blre.2026.101416_bb0875","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.leukres.2010.01.009","article-title":"Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature","volume":"34","author":"Zhang","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2026.101416_bb0880","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5045\/br.2014.49.1.66","article-title":"A rare case of isolated myeloid sarcoma of the small gut with inv(16)(p13;q22) without bone marrow involvement","volume":"49","author":"Mandal","year":"2014","journal-title":"Blood Res"},{"key":"10.1016\/j.blre.2026.101416_bb0885","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00277-001-0412-9","article-title":"A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis","volume":"81","author":"Agis","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb0890","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/1097-0142(19890601)63:11<2192::AID-CNCR2820631122>3.0.CO;2-R","article-title":"Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986","volume":"63","author":"Baer","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb0895","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00019606-200012000-00003","article-title":"Increased incidence of trisomy 8 in acute myeloid Leukemia with skin infiltration (Leukemia cutis)","volume":"9","author":"Sen","year":"2000","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.blre.2026.101416_bb0900","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/10428199609052439","article-title":"Tetrasomy 8 and t(1;11)(p32;q24) in acute myelo-monocytic leukemia with extensive leukemic cutaneous involvement","volume":"20","author":"Ferrara","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2026.101416_bb0905","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-4608(99)00164-8","article-title":"Pentasomy 8 in acute monoblastic Leukemia","volume":"117","author":"Gould","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2026.101416_bb0910","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0002-9440(10)63052-0","article-title":"Granulocytic sarcoma in MLL-positive infant acute myelogenous Leukemia","volume":"159","author":"Park","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2026.101416_bb0915","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-4608(82)90001-2","article-title":"Translocation (9;11)(p21;q23) in three cases of acute monoblastic leukemia","volume":"5","author":"Hagemeijer","year":"1982","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2026.101416_bb0920","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0165-4608(86)90079-8","article-title":"Acute myeloid leukemia with marrow hypereosinophilia and chromosome 16 abnormality","volume":"20","author":"Dachary","year":"1986","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2026.101416_bb0925","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-4608(94)90115-5","article-title":"Translocation (8;17)(p21;q21), a possible variant of t(15;17), in acute promyelocytic leukemia","volume":"72","author":"Miura","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2026.101416_bb0930","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-4608(87)90101-4","article-title":"A unique 8;16 translocation in two infants with poorly differentiated monoblastic leukemia","volume":"24","author":"Bernstein","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2026.101416_bb0935","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/104281904000010783","article-title":"Rearrangement of MLL in a patient with congenital acute monoblastic leukemia and granulocytic sarcoma associated with a t(1;11)(p36;q23) translocation","volume":"46","author":"Douet-Guilbert","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2026.101416_bb0940","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221115005","article-title":"Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed\/refractory extramedullary disease after allogeneic hematopoietic cell transplantation","volume":"13","author":"Kunadt","year":"2022","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb0945","first-page":"378","article-title":"Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax\/ hypomethylating agents","volume":"110","author":"Kayser","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb0950","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13059-021-02362-7","article-title":"SpatialDWLS: accurate deconvolution of spatial transcriptomic data","volume":"22","author":"Dong","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.blre.2026.101416_bb0955","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1093\/nar\/gkab043","article-title":"SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes","volume":"49","author":"Elosua-Bayes","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.blre.2026.101416_bb0960","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","article-title":"Robust decomposition of cell type mixtures in spatial transcriptomics","volume":"40","author":"Cable","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.blre.2026.101416_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201900221","article-title":"Spatially resolved transcriptomes\u2014next generation tools for tissue exploration","volume":"42","author":"Asp","year":"2020","journal-title":"BioEssays"},{"key":"10.1016\/j.blre.2026.101416_bb0970","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aaf2403","article-title":"Visualization and analysis of gene expression in tissue sections by spatial transcriptomics","volume":"353","author":"St\u00e5hl","year":"2016","journal-title":"Science"},{"issue":"Supplement 1","key":"10.1016\/j.blre.2026.101416_bb0975","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1182\/blood-2024-201932","article-title":"Multimodal spatial transcriptomic profiling elucidates niche-specific dynamics in medullary and extramedullary acute myeloid Leukemia","volume":"144","author":"Dasdemir","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb0980","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa6090","article-title":"Spatially resolved, highly multiplexed RNA profiling in single cells","volume":"348","author":"Chen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.blre.2026.101416_bb0985","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5691","article-title":"Three-dimensional intact-tissue sequencing of single-cell transcriptional states","volume":"361","author":"Wang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.blre.2026.101416_bb0990","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaw1219","article-title":"Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution","volume":"363","author":"Rodriques","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.blre.2026.101416_bb0995","series-title":"Bone marrow spatial transcriptomics reveals a myeloma cell architecture with dysfunctional T-cell distribution, neutrophil traps, and inflammatory signaling","author":"Sudupe","year":"2024"},{"key":"10.1016\/j.blre.2026.101416_bb1000","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41556-019-0439-6","article-title":"Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization","volume":"22","author":"Baccin","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"Supplement 1","key":"10.1016\/j.blre.2026.101416_bb1005","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1182\/blood-2024-205328","article-title":"Integrating spatial transcriptome, single-cell sequencing and histopathology reveals bone marrow spatial heterogenous in AML patients","volume":"144","author":"Lin","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb1010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.18.01468","article-title":"Initial diagnostic work-up of acute Leukemia: ASCO clinical practice guideline endorsement of the College of American Pathologists and American Society of Hematology guideline","volume":"37","author":"De Haas","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.blre.2026.101416_bb1015","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1002\/cncr.34459","article-title":"Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations","volume":"128","author":"Ball","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb1020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmoldx.2019.11.004","article-title":"Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival","volume":"22","author":"Werstein","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.blre.2026.101416_bb1025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.1972.03210030043011","article-title":"Positive gallium 677 photoscan in myeloblastoma","volume":"222","author":"Larson","year":"1972","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2026.101416_bb1030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1148\/radiology.190.3.8115614","article-title":"Granulocytic sarcoma in childhood leukemia: imaging features","volume":"190","author":"Pui","year":"1994","journal-title":"Radiology"},{"issue":"12 Suppl","key":"10.1016\/j.blre.2026.101416_bb1035","article-title":"PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma","volume":"91","author":"Karlin","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb1040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1095-0397(01)00056-5","article-title":"Detection of extramedullary infiltrates in acute myelogenous Leukemia with whole-body positron emission tomography and 2-Deoxy-2-[18F]-Fluoro-D-glucose","volume":"4","author":"Kuenzle","year":"2002","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.blre.2026.101416_bb1045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/RLU.0b013e31815ef799","article-title":"Granulocytic sarcomas evaluated with F-18-fluorodeoxyglucose PET","volume":"33","author":"Mantzarides","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.blre.2026.101416_bb1050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261550","article-title":"Analysis of PET parameters predicting response to radiotherapy for myeloid sarcoma","volume":"16","author":"Choi","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.blre.2026.101416_bb1055","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3324\/haematol.2019.223032","article-title":"The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET\/CT: final results from the prospective PETAML trial","volume":"105","author":"St\u00f6lzel","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101416_bb1060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2016.04.001","article-title":"Extramedullary acute myelogenous leukemia","volume":"30","author":"Solh","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2026.101416_bb1065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1988.6.3.495","article-title":"High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia","volume":"6","author":"Cassileth","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb1070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12885-015-1376-9","article-title":"Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults","volume":"15","author":"Cheng","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb1075","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/RLU.0000000000001897","article-title":"Clinical significance of a solitary cold thyroid nodule in the setting of graves disease","volume":"43","author":"Achong","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.blre.2026.101416_bb1080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.26253","article-title":"Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease","volume":"118","author":"Shihadeh","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb1085","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2026.101416_bb1090","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1212\/WNL.0b013e31828ab295","article-title":"Pearls and oy-sters: the utility of cytology and flow cytometry in the diagnosis of leptomeningeal leukemia","volume":"80","author":"Gold","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2026.101416_bb1095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminhematol.2018.02.006","article-title":"Involvement of central nervous system in adult patients with acute myeloid leukemia: incidence and impact on outcome","volume":"55","author":"Del Principe","year":"2018","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb1100","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood-2009-03-206672","article-title":"PD-1\/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model","volume":"114","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb1105","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/10428194.2017.1344905","article-title":"The emerging role of immune checkpoint based approaches in AML and MDS","volume":"59","author":"Boddu","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2026.101416_bb1110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJMoa1601202","article-title":"Ipilimumab for patients with relapse after allogeneic transplantation","volume":"375","author":"Davids","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101416_bb1115","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/bloodadvances.2018029850","article-title":"Hematopoietic cytokines mediate resistance to targeted therapy in FLT3-ITD acute myeloid leukemia","volume":"3","author":"Sung","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101416_bb1120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bjh.12599","article-title":"Bone marrow stroma-mediated resistance to FLT3 inhibitors in FLT3-ITD AML is mediated by persistent activation of extracellular regulated kinase","volume":"164","author":"Yang","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101416_bb1135","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrclinonc.2012.150","article-title":"The European LeukemiaNet AML working party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach","volume":"9","author":"Cornelissen","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb1140","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/ijc.70024","article-title":"Prognostic impact of extramedullary disease in acute myeloid leukemia: a meta-analysis","volume":"157","author":"Lin","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb1145","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid Leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN Cancer research group trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"JCO"},{"key":"10.1016\/j.blre.2026.101416_bb1150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/his.13864","article-title":"Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia","volume":"75","author":"Ullman","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.blre.2026.101416_bb1155","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb1160","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101416_bb1165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ejh.70021","article-title":"Extramedullary acute myeloid Leukemia: evaluating azacitidine\u2014Venetoclax combination outcomes and the role of molecular genetics and bone marrow involvement","volume":"115","author":"Palumbo","year":"2025","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2026.101416_bb1170","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000534026","article-title":"Limited efficacy of Venetoclax combination regimens in acute myeloid Leukemia with extramedullary relapse","volume":"147","author":"Bae","year":"2024","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2026.101416_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2026.100201","article-title":"Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics","volume":"3","author":"Aguirre","year":"2026","journal-title":"Blood Neoplasia"},{"key":"10.1016\/j.blre.2026.101416_bb1180","doi-asserted-by":"crossref","first-page":"26340","DOI":"10.1073\/pnas.2014732117","article-title":"Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23\/KMT2A","volume":"117","author":"Bill","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2026.101416_bb1185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12185-020-02855-4","article-title":"Successful treatment with gilteritinib for isolated extramedullary relapse of acute myeloid leukemia with FLT3-ITD mutation after allogeneic stem cell transplantation","volume":"112","author":"Kida","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb1190","article-title":"Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Kumode","year":"2020","journal-title":"Leukemia Res Rep"},{"key":"10.1016\/j.blre.2026.101416_bb1195","article-title":"Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation","volume":"18","author":"Iannotta","year":"2022","journal-title":"Leukemia Res Rep"},{"key":"10.1016\/j.blre.2026.101416_bb1200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jocn.2021.05.001","article-title":"Intracranial myeloid sarcoma presentation in distant acute myeloid leukemia remission","volume":"89","author":"Lee","year":"2021","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.blre.2026.101416_bb1205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood.2024026232","article-title":"Menin inhibitors in the treatment of acute myeloid leukemia","volume":"145","author":"Huls","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb1210","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.ijrobp.2011.02.057","article-title":"Radiation therapy for chloroma (granulocytic sarcoma)","volume":"82","author":"Bakst","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.blre.2026.101416_bb1215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.prro.2011.02.010","article-title":"Radiation therapy for leukemia cutis","volume":"1","author":"Bakst","year":"2011","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb1220","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41409-018-0093-9","article-title":"Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes","volume":"53","author":"Alhashim","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2026.101416_bb1225","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.leukres.2013.08.017","article-title":"Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia","volume":"37","author":"Shimizu","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2026.101416_bb1230","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.bbmt.2012.05.010","article-title":"Extramedullary relapse of acute myeloid Leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse","volume":"18","author":"Yoshihara","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2026.101416_bb1235","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bbmt.2014.03.030","article-title":"Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia","volume":"20","author":"Ge","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2026.101416_bb1240","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbmt.2017.03.023","article-title":"Isolated extramedullary relapse of acute Leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse","volume":"23","author":"Shem-Tov","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2026.101416_bb1245","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/TP.0b013e3182481113","article-title":"Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation","volume":"93","author":"St\u00f6lzel","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2026.101416_bb1250","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/hematology.2019000005","article-title":"Clonal evolution and immune evasion in posttransplantation relapses","volume":"2019","author":"Vago","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2026.101416_bb1255","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2217\/imt-2019-0215","article-title":"Extramedullary leukemia relapse after allogeneic stem cell transplantation: a novel mechanism of immune escape?","volume":"12","author":"Gkirkas","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.blre.2026.101416_bb1260","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31014","article-title":"Extramedullary infiltration in pediatric acute myeloid leukemia: results from the therapeutically applicable research to generate effective treatments (TARGET) initiative","volume":"71","author":"Li","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2026.101416_bb1265","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood.2022017686","article-title":"Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-na\u00efve settings","volume":"141","author":"Garcia","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb1270","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.2022018246","article-title":"Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease","volume":"141","author":"Penter","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101416_bb1275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41375-025-02764-7","article-title":"Different immunotherapeutic combinations enhance specific T cell immune responses against leukemic cells, as well as leukemic progenitor cells, in acute myeloid leukemia","volume":"40","author":"Greiner","year":"2026","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2026.101416_bb1280","article-title":"A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb1285","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1608433","article-title":"Overcoming resistance to immune checkpoint inhibitor therapy in acute myeloid leukemia","volume":"16","author":"Agrawal","year":"2026","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb1290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","article-title":"Acute myeloid Leukemia, version 3.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Pollyea","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.blre.2026.101416_bb1295","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1080\/10428194.2023.2248331","article-title":"Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement","volume":"64","author":"Sastow","year":"2023","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2026.101416_bb1300","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","article-title":"Current management and challenges of malignant disease in the CNS in paediatric leukaemia","volume":"9","author":"Pui","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb1305","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00277-011-1171-x","article-title":"Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation","volume":"90","author":"Neumann","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2026.101416_bb1310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-021-04356-5","article-title":"Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement","volume":"89","author":"Condorelli","year":"2022","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.blre.2026.101416_bb1315","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1402970","article-title":"The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R\/R AML with CNS relapse: a case report","volume":"14","author":"Ji","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2026.101416_bb1320","series-title":"Single cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML","author":"Gui","year":"2025"},{"key":"10.1016\/j.blre.2026.101416_bb1325","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2022.12.015","article-title":"Coordinated cancer chaos","volume":"186","author":"Messal","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.blre.2026.101416_bb1330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176594","article-title":"Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time","volume":"14","author":"Almagro","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101416_bb1335","series-title":"Spotlight on 10x Visium: a multi-sample protocol comparison of spatial technologies","author":"Du MRM","year":"2024"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2600055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2600055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:10:51Z","timestamp":1787951451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X2600055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":265,"alternative-id":["S0268960X2600055X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101416","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A tale of two sites \u2013 Distinct spatial differences between bone marrow and extramedullary AML","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101416"}}